Genetics and biology of pancreatic ductal adenocarcinoma

Ying et al. review pancreatic ductal adenocarcinoma (PDAC) genetics and biology, particularly altered cancer cell metabolism, the complexity of immune regulation in the tumor microenvironment, and impaired DNA repair processes.

[1]  Y. Samuels,et al.  Oncogenic mutations of PIK3CA in human cancers. , 2004, Current topics in microbiology and immunology.

[2]  H. Buhr,et al.  Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer , 2003, Journal of Gastrointestinal Surgery.

[3]  Ralph Weissleder,et al.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Sharpless,et al.  Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent Apoptosis , 2006, Molecular and Cellular Biology.

[5]  S. Rane,et al.  Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. , 2006, Cytokine & growth factor reviews.

[6]  T. Jacks,et al.  Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. , 2006, Cancer research.

[7]  E. Furth,et al.  Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.

[8]  D. Albanes,et al.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.

[9]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[10]  N. Maitland,et al.  A tumour stem cell hypothesis for the origins of prostate cancer , 2005, BJU international.

[11]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[12]  D. Melton,et al.  β-Catenin is essential for pancreatic acinar but not islet development , 2005, Development.

[13]  M. de Andrade,et al.  Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma , 2005, Gut.

[14]  C. Manetopoulos,et al.  The Notch pathway in cancer: differentiation gone awry. , 2005, European journal of cancer.

[15]  K. Lim,et al.  Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. , 2005, Cancer cell.

[16]  S. Ekker,et al.  Wnt5 signaling in vertebrate pancreas development , 2005, BMC Biology.

[17]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[18]  Geert J. P. L. Kops,et al.  On the road to cancer: aneuploidy and the mitotic checkpoint , 2005, Nature Reviews Cancer.

[19]  J. Huelsken,et al.  Pancreas-Specific Deletion of β-Catenin Reveals Wnt-Dependent and Wnt-Independent Functions during Development , 2005, Current Biology.

[20]  C. Hill,et al.  Smad4 Dependency Defines Two Classes of Transforming Growth Factor β (TGF-β) Target Genes and Distinguishes TGF-β-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses , 2005, Molecular and Cellular Biology.

[21]  R. DePinho,et al.  Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. , 2005, Cancer cell.

[22]  M. Sundaram,et al.  The love-hate relationship between Ras and Notch. , 2005, Genes & development.

[23]  S. Leach,et al.  Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates , 2005, Development.

[24]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[25]  D. Cimini,et al.  Aneuploidy: a matter of bad connections. , 2005, Trends in cell biology.

[26]  R. Hruban,et al.  Genome-wide aberrations in pancreatic adenocarcinoma. , 2005, Cancer genetics and cytogenetics.

[27]  C. Der,et al.  Signaling Interplay in Ras Superfamily Function , 2005, Current Biology.

[28]  T. Golub,et al.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.

[29]  L. Chin,et al.  High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Hruban,et al.  Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion , 2005, Modern Pathology.

[31]  J. Fleming,et al.  Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras–Directed Therapy , 2005, Molecular Cancer Research.

[32]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[33]  M. Baccarini.  Second nature: Biological functions of the Raf‐1 “kinase” , 2005, FEBS letters.

[34]  M. McMahon,et al.  Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. , 2005, Cancer research.

[35]  Robert Tibshirani,et al.  Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. , 2005, Neoplasia.

[36]  J. Lacal,et al.  Rho GTPase expression in tumourigenesis: Evidence for a significant link , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  M. Shipitsin,et al.  Activation of RalA is critical for Ras-induced tumorigenesis of human cells. , 2005, Cancer cell.

[38]  P. Comoglio,et al.  Cancer therapy: can the challenge be MET? , 2005, Trends in molecular medicine.

[39]  M. White,et al.  Ral GTPases: corrupting the exocyst in cancer cells. , 2005, Trends in cell biology.

[40]  L. Chin,et al.  Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma , 2005, Molecular and Cellular Biology.

[41]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[42]  D. Hardie,et al.  New roles for the LKB1-->AMPK pathway. , 2005, Current opinion in cell biology.

[43]  Gerard C Blobe,et al.  Role of transforming growth factor Beta in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Hruban,et al.  Precursors to Invasive Pancreatic Cancer , 2005, Advances in anatomic pathology.

[45]  Michael Goggins,et al.  Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. , 2005, Cancer research.

[46]  Krister Wennerberg,et al.  The Ras superfamily at a glance , 2005, Journal of Cell Science.

[47]  B. Sipos,et al.  Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells. , 2005, Cancer research.

[48]  R. Fonseca,et al.  Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. , 2005, Cancer cell.

[49]  J. Mesirov,et al.  An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.

[50]  T. Lange,et al.  Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence , 2004, Current Biology.

[51]  S. Natsugoe,et al.  Impact of Vascular Endothelial Growth Factor-C and -D Expression in Human Pancreatic Cancer , 2004, Clinical Cancer Research.

[52]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[53]  David M. Berman,et al.  Tissue repair and stem cell renewal in carcinogenesis , 2004, Nature.

[54]  C. Lengauer,et al.  Aneuploidy and cancer , 2004, Nature.

[55]  Yixin Yao,et al.  The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells , 2004, Oncogene.

[56]  N. Sharpless,et al.  Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.

[57]  I. Weissman,et al.  JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells , 2004, Cell.

[58]  Eithne Costello,et al.  Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis , 2004, International journal of cancer.

[59]  David F. Kashatus,et al.  The Nuclear Factor κB Subunits RelA/p65 and c-Rel Potentiate but Are Not Required for Ras-Induced Cellular Transformation , 2004, Cancer Research.

[60]  Y. Qi,et al.  p19ARF directly and differentially controls the functions of c-Myc independently of p53 , 2004, Nature.

[61]  Robert Jaster,et al.  Molecular regulation of pancreatic stellate cell function , 2004, Molecular Cancer.

[62]  Mathew J Garnett,et al.  Guilty as charged: B-RAF is a human oncogene. , 2004, Cancer cell.

[63]  T. Kadesch,et al.  Notch signaling: the demise of elegant simplicity. , 2004, Current opinion in genetics & development.

[64]  P. Dirks,et al.  Cancer stem cells in nervous system tumors , 2004, Oncogene.

[65]  Andrew L Warshaw,et al.  Cystic Neoplasms of the Pancreas , 2006 .

[66]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[67]  F. Real,et al.  Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas , 2004, Development.

[68]  G. Peters,et al.  Contribution of p16(INK4a) to replicative senescence of human fibroblasts. , 2004, Experimental cell research.

[69]  D. Bar-Sagi,et al.  Oncogenic K-ras Drives Cell Cycle Progression and Phenotypic Conversion of Primary Pancreatic Duct Epithelial Cells , 2004, Cancer Research.

[70]  K. Chin,et al.  In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.

[71]  R. Hruban,et al.  Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients , 2004, The Journal of experimental medicine.

[72]  S. Artavanis-Tsakonas,et al.  Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. , 2004, The American journal of pathology.

[73]  R. Hruban,et al.  Functional defects in the fanconi anemia pathway in pancreatic cancer cells. , 2004, The American journal of pathology.

[74]  R. Weinberg,et al.  Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.

[75]  Olca Basturk,et al.  Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas , 2004, The American journal of surgical pathology.

[76]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[77]  Helmut Friess,et al.  Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation. , 2004, International journal of oncology.

[78]  R. DePinho,et al.  Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. , 2004, Genes & development.

[79]  Richard A. Woo,et al.  Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. , 2004, Genes & development.

[80]  John M Sedivy,et al.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.

[81]  M. Korc,et al.  Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines , 2004, Clinical Cancer Research.

[82]  Douglas A. Melton,et al.  Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation , 2004, Nature.

[83]  N. Chandler,et al.  Increased expression of NF-κB subunits in human pancreatic cancer cells1,2 ☆ , 2004 .

[84]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[85]  J. Veltman,et al.  Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. , 2004, Cancer research.

[86]  E. Van Cutsem,et al.  Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  D. Morrison,et al.  Signal Transduction: IMPlications for Ras-Dependent ERK Signaling , 2004, Current Biology.

[88]  D. Galloway,et al.  Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence , 2004, Molecular and Cellular Biology.

[89]  R. DePinho,et al.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.

[90]  Yusuke Nakamura,et al.  Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection , 2004, Oncogene.

[91]  G. Koehl,et al.  Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer , 2004, Clinical Cancer Research.

[92]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[93]  J. Cameron,et al.  Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. , 2004, The American journal of pathology.

[94]  Eric C. Lai,et al.  Notch signaling: control of cell communication and cell fate , 2004, Development.

[95]  Michael Goggins,et al.  Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling , 2004, Oncogene.

[96]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[97]  Hans C Clevers,et al.  Complete Polarization of Single Intestinal Epithelial Cells upon Activation of LKB1 by STRAD , 2004, Cell.

[98]  E. Lin,et al.  NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells , 2004 .

[99]  H. Friess,et al.  Adenovirus-Mediated Transfer of a Truncated Fibroblast Growth Factor (FGF) Type I Receptor Blocks FGF-2 Signaling in Multiple Pancreatic Cancer Cell Lines , 2004, Pancreas.

[100]  D. Pellman,et al.  From polyploidy to aneuploidy, genome instability and cancer , 2004, Nature Reviews Molecular Cell Biology.

[101]  H. Friess,et al.  Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors , 2004, Journal of Molecular Medicine.

[102]  H. Varmus,et al.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. , 2003, Genes & development.

[103]  R. DePinho,et al.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.

[104]  J. Jensen,et al.  FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. , 2003, Developmental biology.

[105]  Marina Pasca di Magliano,et al.  Hedgehog signalling in cancer formation and maintenance , 2003, Nature Reviews Cancer.

[106]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[107]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[108]  D. Melton,et al.  Notch signaling controls multiple steps of pancreatic differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[109]  D. Melton,et al.  Genes, signals, and lineages in pancreas development. , 2003, Annual review of cell and developmental biology.

[110]  L. Beckett,et al.  Incidence, mechanism and prognostic value of activated AKT in pancreas cancer , 2003, British Journal of Cancer.

[111]  F. Greten,et al.  Pattern of secondary genomic changes in pancreatic tumors of Tgfα/Trp53+/− transgenic mice , 2003 .

[112]  J. Massagué,et al.  Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer , 2003, Nature Reviews Cancer.

[113]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[114]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[115]  F. Motoi,et al.  Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells , 2003, Oncogene.

[116]  L. Wakefield,et al.  TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression , 2003 .

[117]  R. Hruban,et al.  BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. , 2003, The American journal of pathology.

[118]  H. Edlund,et al.  Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[119]  G. Peters,et al.  Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. , 2003, Cancer cell.

[120]  K. Raj,et al.  The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.

[121]  R. DePinho,et al.  LKB1 (XEEK1) regulates Wnt signalling in vertebrate development , 2003, Nature Cell Biology.

[122]  D. Carbone,et al.  Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer. , 2003, Cancer research.

[123]  K. Yamasawa,et al.  BRAF and K-ras gene mutations in human pancreatic cancers. , 2003, Cancer letters.

[124]  L. Ellis,et al.  Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. , 2003, The American journal of pathology.

[125]  J. Cameron,et al.  Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray , 2003, Modern Pathology.

[126]  C. Pilarsky,et al.  Gene expression profiles of microdissected pancreatic ductal adenocarcinoma , 2003, Virchows Archiv.

[127]  Masashi Narita,et al.  Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.

[128]  J. Hald,et al.  Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. , 2003, Developmental biology.

[129]  E. K. Maloney,et al.  An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. , 2003, Cancer research.

[130]  Manuel Serrano,et al.  Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.

[131]  R. Hruban,et al.  Polymorphisms of SPINK1 N34S and CFTR in Patients with Sporadic and Familial Pancreatic Cancer , 2003, Cancer biology & therapy.

[132]  M. Imamura,et al.  Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. , 2003, Surgery.

[133]  L. Feig.  Ral-GTPases: approaching their 15 minutes of fame. , 2003, Trends in cell biology.

[134]  Domenico Coppola,et al.  Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. , 2003, Human pathology.

[135]  M. White,et al.  RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survival , 2003, EMBO reports.

[136]  A. D. de González,et al.  A meta-analysis of obesity and the risk of pancreatic cancer , 2003, British Journal of Cancer.

[137]  R. Schmid,et al.  Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer , 2003, International journal of cancer.

[138]  H. Varmus,et al.  Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[139]  N. Perkins,et al.  p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor , 2003 .

[140]  E. Montgomery,et al.  Loss of Stk11/Lkb1 Expression in Pancreatic and Biliary Neoplasms , 2003, Modern Pathology.

[141]  R. Hruban,et al.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.

[142]  C. J. Collins,et al.  Involvement of the INK4a/Arf gene locus in senescence , 2003, Aging cell.

[143]  M. Barbacid,et al.  RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.

[144]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[145]  A. Arlt,et al.  Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death , 2003, Oncogene.

[146]  C. Mathew,et al.  Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.

[147]  F. Brembeck,et al.  The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. , 2003, Cancer research.

[148]  D. Longnecker,et al.  Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. , 2003, Cancer research.

[149]  Christine A Iacobuzio-Donahue,et al.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.

[150]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[151]  R. Hruban,et al.  Familial pancreatic cancer: where are we in 2003? , 2003, Journal of the National Cancer Institute.

[152]  Mei-Ling Kuo,et al.  Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. , 2003, Molecular cell.

[153]  Douglas B. Evans,et al.  Function of Nuclear Factor κB in Pancreatic Cancer Metastasis , 2003 .

[154]  Douglas B. Evans,et al.  NF-κB in pancreatic cancer , 2003 .

[155]  C. Cordon-Cardo,et al.  Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer , 2003, Nature Medicine.

[156]  Juliana R. Brown,et al.  Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis , 2003, Mechanisms of Development.

[157]  Mattias Höglund,et al.  Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer , 2002, Genes, chromosomes & cancer.

[158]  J. Kench,et al.  DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[159]  Scott E Kern,et al.  Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. , 2002, The American journal of pathology.

[160]  Masato Nakamura,et al.  Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line. , 2002, International journal of oncology.

[161]  Douglas B. Evans,et al.  Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[162]  S. Orsulic.  An RCAS-TVA-based approach to designer mouse models , 2002, Mammalian Genome.

[163]  Y. A. Minamishima,et al.  Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[164]  Douglas B. Evans,et al.  The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis , 2002, Oncogene.

[165]  Douglas F Easton,et al.  Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.

[166]  Ronald A. DePinho,et al.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation , 2002, Nature.

[167]  C. Wright,et al.  The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors , 2002, Nature Genetics.

[168]  H. Shirasawa,et al.  Dominant negative MEKK1 inhibits survival of pancreatic cancer cells , 2002, Oncogene.

[169]  W. Hahn,et al.  Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells , 2002, Nature Medicine.

[170]  H. Hamada,et al.  Gene Therapy for Pancreatic Cancer Using an Adenovirus Vector Encoding Soluble flt-1 Vascular Endothelial Growth Factor Receptor , 2002, Pancreas.

[171]  L. Chin,et al.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes. , 2002, Cancer cell.

[172]  R. DePinho,et al.  Connecting chromosomes, crisis, and cancer. , 2002, Science.

[173]  S. Kitano,et al.  Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor , 2002, Cancer Gene Therapy.

[174]  Tatjana Crnogorac-Jurcevic,et al.  Expression profiling of microdissected pancreatic adenocarcinomas , 2002, Oncogene.

[175]  Scott E Kern,et al.  Focus on pancreas cancer. , 2002, Cancer cell.

[176]  M. Korc,et al.  IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells. , 2002, Gastroenterology.

[177]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[178]  A. Balmain,et al.  Metastasis is driven by sequential elevation of H-ras and Smad2 levels , 2002, Nature Cell Biology.

[179]  Kathleen M Murphy,et al.  Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. , 2002, Cancer research.

[180]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[181]  C. Boland,et al.  Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers , 2002, Oncogene.

[182]  G. Peters,et al.  INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence , 2002, The EMBO journal.

[183]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[184]  D. Melton,et al.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.

[185]  Haiyong Han,et al.  Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. , 2002, Cancer research.

[186]  Kimberly Walter,et al.  Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. , 2002, The American journal of pathology.

[187]  R. DePinho,et al.  Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. , 2002, Cancer cell.

[188]  Leonid Kruglyak,et al.  A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. , 2002, American journal of human genetics.

[189]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[190]  K. Lillemoe,et al.  Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. , 2002, Cancer research.

[191]  David Tosh,et al.  How cells change their phenotype , 2002, Nature Reviews Molecular Cell Biology.

[192]  K. Okita,et al.  Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. , 2002, Cancer research.

[193]  T. Jacks,et al.  Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.

[194]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[195]  J. Downward,et al.  Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.

[196]  M. Loda,et al.  Obligate Roles for p16Ink4a and p19Arf-p53 in the Suppression of Murine Pancreatic Neoplasia , 2002, Molecular and Cellular Biology.

[197]  S. Kern,et al.  Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families , 2002, Cancer.

[198]  J. Testa,et al.  Frequent activation of AKT2 kinase in human pancreatic carcinomas , 2002, Journal of cellular biochemistry.

[199]  M. Korc,et al.  Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. , 2002, Molecular cancer therapeutics.

[200]  T. Jacks,et al.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.

[201]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[202]  J. Cameron,et al.  STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. , 2001, The American journal of pathology.

[203]  J. Cameron,et al.  The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[204]  P. Ingham,et al.  Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.

[205]  R. Derynck,et al.  TGF-β signaling in cancer – a double-edged sword , 2001 .

[206]  K. Matsumoto,et al.  Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. , 2001, Cancer research.

[207]  D. Gisselsson,et al.  Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[208]  I. Fidler,et al.  Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. , 2001, International journal of oncology.

[209]  Charles J. Sherr,et al.  The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.

[210]  A. Berns,et al.  Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice , 2001, Nature.

[211]  D. Carrasco,et al.  Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.

[212]  M. Korc,et al.  Soluble Type II Transforming Growth Factor-β (TGF-β) Receptor Inhibits TGF-β Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation , 2001 .

[213]  G A Colditz,et al.  Physical activity, obesity, height, and the risk of pancreatic cancer. , 2001, JAMA.

[214]  T. Gress,et al.  TGF‐β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase‐2 and the urokinase plasminogen activator system , 2001, International journal of cancer.

[215]  H. Blau,et al.  The Evolving Concept of a Stem Cell Entity or Function? , 2001, Cell.

[216]  J. Cameron,et al.  Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. , 2001, Cancer research.

[217]  T. Seufferlein,et al.  Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. , 2001, Cancer research.

[218]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[219]  W. Schmiegel,et al.  Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. , 2001, The American journal of pathology.

[220]  G. Ying,et al.  Familial risk of pancreatic cancer. , 2001, Journal of the National Cancer Institute.

[221]  Y. A. Minamishima,et al.  Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. , 2001, Cancer genetics and cytogenetics.

[222]  M. Korc,et al.  Overexpression of Lymphangiogenic Growth Factor VEGF-C in Human Pancreatic Cancer , 2001, Pancreas.

[223]  L. Claesson‐Welsh,et al.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.

[224]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[225]  P. Edwards,et al.  Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping. , 2001 .

[226]  T. Mattfeldt,et al.  A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. , 2001, Genes & development.

[227]  S. K. Kim,et al.  Intercellular signals regulating pancreas development and function. , 2001, Genes & development.

[228]  X. Estivill,et al.  Cystic fibrosis transmembrane regulator ( CFTR ) Ä F 508 mutation and 5 T allele in patients with chronic pancreatitis and exocrine pancreatic cancer , 2000 .

[229]  J. Ringel,et al.  Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma , 2001 .

[230]  R Montironi,et al.  p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.

[231]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[232]  B. Wiedenmann,et al.  De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. , 2000, Gastroenterology.

[233]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[234]  S. Leach,et al.  p53-dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[235]  P. Duesberg,et al.  Aneuploidy, the somatic mutation that makes cancer a species of its own. , 2000, Cell motility and the cytoskeleton.

[236]  M. Tsao,et al.  Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. , 2000, Cancer research.

[237]  R. DePinho,et al.  Cellular Senescence Minireview Mitotic Clock or Culture Shock? , 2000, Cell.

[238]  O. Volpert,et al.  Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[239]  Lynda Chin,et al.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice , 2000, Nature.

[240]  Å. Borg,et al.  High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma Families , 2000 .

[241]  R H Hruban,et al.  Progression model for pancreatic cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[242]  S. Thorgeirsson,et al.  Role of the IκB Kinase Complex in Oncogenic Ras- and Raf-Mediated Transformation of Rat Liver Epithelial Cells , 2000, Molecular and Cellular Biology.

[243]  J. Rüschoff,et al.  Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. , 2000, The American journal of pathology.

[244]  J. Struewing,et al.  Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. , 2000, Journal of the National Cancer Institute.

[245]  H. Watanabe,et al.  Genetic progression and divergence in pancreatic carcinoma. , 2000, The American journal of pathology.

[246]  R. Hruban,et al.  Genetic progression in the pancreatic ducts. , 2000, The American journal of pathology.

[247]  I. Fidler,et al.  Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. , 2000, Cancer research.

[248]  A. Dyer,et al.  Abnormal glucose metabolism and pancreatic cancer mortality. , 2000, JAMA.

[249]  T. Fukuda,et al.  High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma , 2000, Cancer.

[250]  F. Vittimberga,et al.  Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent. , 2000, The Journal of surgical research.

[251]  N. Arens,et al.  Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH) , 2000, The Journal of pathology.

[252]  R. Hruban,et al.  BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. , 2000, The American journal of pathology.

[253]  S. Gallinger,et al.  Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations , 2000, Genes, chromosomes & cancer.

[254]  R. Hruban,et al.  Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. , 2000, Cancer research.

[255]  P. Maisonneuve,et al.  K-ras mutations and benign pancreatic disease , 2000, International journal of pancreatology : official journal of the International Association of Pancreatology.

[256]  G. Capellá,et al.  DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. , 2000, Cancer genetics and cytogenetics.

[257]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[258]  Ryoichiro Kageyama,et al.  Control of endodermal endocrine development by Hes-1 , 2000, Nature Genetics.

[259]  H. Friess,et al.  Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. , 1999, Annals of surgery.

[260]  N. Sarvetnick,et al.  PDX-1 and Msx-2 expression in the regenerating and developing pancreas. , 1999, The Journal of endocrinology.

[261]  H. Friess,et al.  Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. , 1999, Pancreas.

[262]  A. Stemmer-Rachamimov,et al.  Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[263]  David J. Anderson,et al.  Notch signalling controls pancreatic cell differentiation , 1999, Nature.

[264]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[265]  L. Chin,et al.  Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.

[266]  R. Hruban,et al.  Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. , 1999, The American journal of pathology.

[267]  L. Chin,et al.  Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse , 1999, Cell.

[268]  Lynda Chin,et al.  E.: “A Summary of , 1968 .

[269]  Masafumi Nakamura,et al.  Centrosome abnormalities in pancreatic ductal carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[270]  G. Klöppel,et al.  The K‐ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium , 1999, Cancer.

[271]  R. E. Jimenez,et al.  Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. , 1999, The American journal of pathology.

[272]  S. Bonner-Weir,et al.  The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. , 1999, Diabetes.

[273]  R. DePinho,et al.  The INK4A/ARF locus and its two gene products. , 1999, Current opinion in genetics & development.

[274]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[275]  David Hogg,et al.  Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma , 1999, Nature Genetics.

[276]  R. Schmid,et al.  Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. , 1998, Gastroenterology.

[277]  H. Friess,et al.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. , 1998, The Journal of clinical investigation.

[278]  R. Hruban,et al.  Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. , 1998, Cancer research.

[279]  G. Peters,et al.  The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.

[280]  A. Andrén-sandberg,et al.  Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations , 1998, Genes, chromosomes & cancer.

[281]  D. Woods,et al.  Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.

[282]  F. McCormick.  Going for the GAP , 1998, Current Biology.

[283]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[284]  M. Schwarz,et al.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. , 1998, The New England journal of medicine.

[285]  T. Nakamura,et al.  Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. , 1998, The American journal of pathology.

[286]  M. Korc,et al.  Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis , 1998, Gut.

[287]  A. Foulis.  Book Review: AFIP Atlas of Tumot Patholgoy (3rd series, Fascicle 20). Tumours of the Pancreas. Enrico Solcia, Carlo Capella and Gunter Kloppel, Armed Forces Institute of Pathology, Washington, DC , 1998 .

[288]  D. Melton,et al.  Notochord repression of endodermal Sonic hedgehog permits pancreas development. , 1998, Genes & development.

[289]  M. Korc,et al.  Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. , 1998, Gastroenterology.

[290]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[291]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[292]  C. Compton.  Atlas of Tumor Pathology. Tumors of the Pancreas , 1998 .

[293]  G. Riggins,et al.  Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. , 1998, Cancer research.

[294]  J. Cheng,et al.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.

[295]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[296]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[297]  J. Nezu,et al.  Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase , 1998, Nature Genetics.

[298]  S. Narumiya,et al.  Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. , 1998, British Journal of Cancer.

[299]  C. Y. Wang,et al.  Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.

[300]  B Johansson,et al.  Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer , 1997, Genes, chromosomes & cancer.

[301]  L. Chin,et al.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.

[302]  N. Kohl,et al.  CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents. , 1997, Trends in pharmacological sciences.

[303]  H. Edlund,et al.  Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas , 1997, Current Biology.

[304]  M. Korc,et al.  Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions , 1997, Oncogene.

[305]  G. Klöppel,et al.  Tumors of the Pancreas , 1997 .

[306]  H. Friess,et al.  Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[307]  F. Zindy,et al.  Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging , 1997, Oncogene.

[308]  J. Rehfeld,et al.  Expression of gastrin and transforming growth factor-α during duct to islet cell differentiation in the pancreas of duct-ligated adult rats , 1997, Diabetologia.

[309]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[310]  A. Wittinghofer,et al.  The interaction of Ras with GTPase‐activating proteins , 1997, FEBS letters.

[311]  C. Moskaluk,et al.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. , 1997, Cancer research.

[312]  P. Pour.  The role of Langerhans islets in pancreatic ductal adenocarcinoma. , 1997, Frontiers in bioscience : a journal and virtual library.

[313]  S. Goodman,et al.  Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.

[314]  E. Dimagno,et al.  Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. , 1997, Journal of the National Cancer Institute.

[315]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[316]  S. Sebti,et al.  Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines , 1997, Oncogene.

[317]  G A Colditz,et al.  A prospective study of cigarette smoking and the risk of pancreatic cancer. , 1996, Archives of internal medicine.

[318]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[319]  M. Gorry,et al.  Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.

[320]  J. Downward,et al.  Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.

[321]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[322]  R H Hruban,et al.  Familial pancreatic cancer: a review. , 1996, Seminars in oncology.

[323]  B. Hogan,et al.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.

[324]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[325]  G. Prendergast,et al.  Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity , 1995, Molecular and cellular biology.

[326]  H. Friess,et al.  Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[327]  P. Goodfellow,et al.  Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. , 1995, The New England journal of medicine.

[328]  A M Goldstein,et al.  Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. , 1995, The New England journal of medicine.

[329]  M. Tsao,et al.  Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. , 1995, The American journal of pathology.

[330]  T. Miyashita,et al.  Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas. , 1995, British Journal of Cancer.

[331]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[332]  C. Greider,et al.  Developmental and tissue-specific regulation of mouse telomerase and telomere length. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[333]  M. Korc,et al.  Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. , 1995, Cancer research.

[334]  R. Poulsom,et al.  Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. , 1995, Cancer research.

[335]  M. Corey,et al.  The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. , 1995, The New England journal of medicine.

[336]  D. Klimstra,et al.  K-ras mutations in pancreatic ductal proliferative lesions. , 1994, The American journal of pathology.

[337]  S. Stryker,et al.  Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. , 1994, The American journal of pathology.

[338]  D. Hanahan,et al.  Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. , 1994, The American journal of pathology.

[339]  H. Friess,et al.  Induction and expression of amphiregulin in human pancreatic cancer. , 1994, Cancer research.

[340]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[341]  H. Friess,et al.  Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. , 1993, Cancer research.

[342]  H. Ohlsson,et al.  IPF1, a homeodomain‐containing transactivator of the insulin gene. , 1993, The EMBO journal.

[343]  H. Friess,et al.  Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. , 1993, Cancer research.

[344]  R. L. Baldwin,et al.  Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. , 1993, Cancer research.

[345]  R. Palmiter,et al.  Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver , 1993, Molecular and cellular biology.

[346]  H. Friess,et al.  Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. , 1993, Anticancer research.

[347]  H. Friess,et al.  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. , 1992, The Journal of clinical investigation.

[348]  D. Longnecker,et al.  Characterization of the ELSV transgenic mouse model of pancreatic carcinoma. Histologic type of large and small tumors. , 1992, The American journal of pathology.

[349]  N. Lemoine,et al.  Ki-ras oncogene activation in preinvasive pancreatic cancer. , 1992, Gastroenterology.

[350]  N. Lemoine,et al.  Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer , 1991, The Journal of pathology.

[351]  R. Palmiter,et al.  Pancreatic tumor pathogenesis reflects the causative genetic lesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[352]  G. Merlino,et al.  TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.

[353]  R. Palmiter,et al.  Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.

[354]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[355]  R. Hammer,et al.  Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. , 1987, Science.

[356]  R. Palmiter,et al.  Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice , 1987, Cell.

[357]  P. Pour,et al.  Ductal metaplasia of human exocrine pancreas and its association with carcinoma. , 1985, Cancer research.

[358]  I. Fidler,et al.  Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.